Clinical trial
High Dose Chemo With Stem Cell Transplant as Treatment for Multiple Sclerosis That Failed Prior Treatment
NCT01679041
Study timeline
Study start (unknown)2012-11-01Date precision: month
Registry last updated2013-11-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Sclerosisunresolved
Interventions
AlemtuzumabDRUG · verified · RxNorm: alemtuzumab
FludarabineDRUG · verified · RxNorm: fludarabine
CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
Sponsors & collaborators
Seah Lim M.D.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01679041 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.